Miyake, Juliano Andreoli; Benadiba, Marcel; Colquhoun, Alison 
Source: Lipids in Health and Diseases. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAKE, Juliano Andreoli e BENADIBA, Marcel e COLQUHOUN, Alison. Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression. Lipids in Health and Diseases, v. 8, n. 8, 2009Tradução . . Disponível em: https://doi.org/10.1186/1476-511x-8-8. Acesso em: 29 ago. 2024.APA
Miyake, J. A., Benadiba, M., & Colquhoun, A. (2009). Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression. Lipids in Health and Diseases, 8( 8). doi:10.1186/1476-511x-8-8NLM
Miyake JA, Benadiba M, Colquhoun A. Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression [Internet]. Lipids in Health and Diseases. 2009 ; 8( 8):[citado 2024 ago. 29 ] Available from: https://doi.org/10.1186/1476-511x-8-8Vancouver
Miyake JA, Benadiba M, Colquhoun A. Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression [Internet]. Lipids in Health and Diseases. 2009 ; 8( 8):[citado 2024 ago. 29 ] Available from: https://doi.org/10.1186/1476-511x-8-8
